ORMP icon

Oramed Pharmaceuticals

22 hedge funds and large institutions have $5.61M invested in Oramed Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
22
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$62K
Puts
$79K
Net Calls
Net Calls Change

Top Buyers

1 +$127K
2 +$68.3K
3 +$65K
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$48.7K
5
Citadel Advisors
Citadel Advisors
Florida
+$32K

Top Sellers

1 -$180K
2 -$126K
3 -$24K
4
Group One Trading
Group One Trading
Illinois
-$11K
5
Morgan Stanley
Morgan Stanley
New York
-$6.41K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$2.88M
2
$1.87M
3
$228K
4
$182K
5
$126K
6
$68K
7
$65K
8
$57K
9
$36K
10
$32K
11
$30K
12
$16K
13
$7K
14
$7K
15
$2K
16
$2K
17
$1K
18
$1K
19
$1K
20
$2
21
22
23
24